Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Acute delta- and kappa-opioid agonist pretreatment potentiates opioid antagonist-induced suppression of water consumption.

White DA, Ballard ME, Harmon AC, Holtzman SG.

Brain Res Bull. 2008 Aug 15;76(6):597-604. doi: 10.1016/j.brainresbull.2008.04.002. Epub 2008 May 9.

2.

Periadolescent male but not female rats have higher motor activity in response to morphine than do adult rats.

White DA, Michaels CC, Holtzman SG.

Pharmacol Biochem Behav. 2008 Apr;89(2):188-99. doi: 10.1016/j.pbb.2007.12.009. Epub 2007 Dec 15.

3.

Early postnatal stress alters place conditioning to both mu- and kappa-opioid agonists.

Michaels CC, Holtzman SG.

J Pharmacol Exp Ther. 2008 Apr;325(1):313-8. doi: 10.1124/jpet.107.129908. Epub 2008 Jan 18.

PMID:
18203949
4.

The CRF1 receptor antagonist, R121919, attenuates the severity of precipitated morphine withdrawal.

Skelton KH, Oren D, Gutman DA, Easterling K, Holtzman SG, Nemeroff CB, Owens MJ.

Eur J Pharmacol. 2007 Sep 24;571(1):17-24. Epub 2007 Jun 5.

PMID:
17610870
5.

Maternal separation alters ICSS responding in adult male and female rats, but morphine and naltrexone have little affect on that behavior.

Michaels CC, Easterling KW, Holtzman SG.

Brain Res Bull. 2007 Jul 12;73(4-6):310-8. Epub 2007 May 22.

PMID:
17562397
6.
7.

Locomotor response to novelty as a predictor of reactivity to aversive stimuli in the rat.

White DA, Kalinichev M, Holtzman SG.

Brain Res. 2007 May 29;1149:141-8. Epub 2007 Feb 28.

8.

Neonatal stress and litter composition alter sucrose intake in both rat dam and offspring.

Michaels CC, Holtzman SG.

Physiol Behav. 2006 Dec 30;89(5):735-41. Epub 2006 Sep 22.

PMID:
16996094
9.

Modeling the onset of drug dependence: a consideration of the requirement for protein synthesis.

Joyce AR, Easterling K, Holtzman SG, Kuhar MJ.

J Theor Biol. 2006 Jun 21;240(4):531-7. Epub 2005 Dec 13.

PMID:
16352315
10.

Periadolescent morphine exposure alters subsequent behavioral sensitivity to morphine in adult rats.

White DA, Holtzman SG.

Eur J Pharmacol. 2005 Dec 28;528(1-3):119-23.

PMID:
16321380
11.

Naltrexone-induced conditioned place aversion following a single dose of morphine in the rat.

White DA, Hwang ML, Holtzman SG.

Pharmacol Biochem Behav. 2005 Jul;81(3):451-8.

PMID:
15907990
12.

Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey: a further characterization.

White DA, Holtzman SG.

J Pharmacol Exp Ther. 2005 Jul;314(1):374-82. Epub 2005 Apr 20.

PMID:
15843500
13.
14.
16.

In rats, acute morphine dependence results in antagonist-induced response suppression of intracranial self-stimulation.

Easterling KW, Holtzman SG.

Psychopharmacology (Berl). 2004 Sep;175(3):287-95.

PMID:
15024547
17.

Discriminative stimulus effects of acute morphine followed by naltrexone in the squirrel monkey.

White DA, Holtzman SG.

Psychopharmacology (Berl). 2003 May;167(2):203-10. Epub 2003 Mar 18.

PMID:
12644889
22.

Long-lasting changes in stress-induced corticosterone response and anxiety-like behaviors as a consequence of neonatal maternal separation in Long-Evans rats.

Kalinichev M, Easterling KW, Plotsky PM, Holtzman SG.

Pharmacol Biochem Behav. 2002 Aug;73(1):131-40.

PMID:
12076732
23.

Biochemical and behavioral characterization of novel methylphenidate analogs.

Schweri MM, Deutsch HM, Massey AT, Holtzman SG.

J Pharmacol Exp Ther. 2002 May;301(2):527-35.

PMID:
11961053
24.
25.

Central discriminative effects of morphine in rats: training via intracerebroventricular administration.

Easterling KW, Holtzman SG.

Brain Res Bull. 2001 Dec;56(6):545-51.

PMID:
11786240
26.

Early neonatal experience of Long-Evans rats results in long-lasting changes in morphine tolerance and dependence.

Kalinichev M, Easterling KW, Holtzman SG.

Psychopharmacology (Berl). 2001 Sep;157(3):305-12.

PMID:
11605087
27.

The role of dopamine in the locomotor stimulant effects and tolerance to these effects of caffeine.

Powell KR, Iuvone PM, Holtzman SG.

Pharmacol Biochem Behav. 2001 May-Jun;69(1-2):59-70.

PMID:
11420069
28.

Repeated neonatal maternal separation alters morphine-induced antinociception in male rats.

Kalinichev M, Easterling KW, Holtzman SG.

Brain Res Bull. 2001 Apr;54(6):649-54.

PMID:
11403991
29.

Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.

White DA, Holtzman SG.

J Pharmacol Exp Ther. 2001 Jul;298(1):156-64.

PMID:
11408537
30.
31.
32.

Agonist efficacy, drug dependence, and medications development: preclinical evaluation of opioid, dopaminergic, and GABAA-ergic ligands.

Bergman J, France CP, Holtzman SG, Katz JL, Koek W, Stephens DN.

Psychopharmacology (Berl). 2000 Dec;153(1):67-84. Review.

PMID:
11255930
33.

Parametric evaluation of the development of sensitization to the effects of morphine on locomotor activity.

Powell KR, Holtzman SG.

Drug Alcohol Depend. 2001 Mar 1;62(1):83-90.

PMID:
11173171
34.

Acute opioid but not benzodiazepine dependence in rats responding for intracranial self-stimulation.

Easterling KW, Plovnick RM, Holtzman SG.

Psychopharmacology (Berl). 2000 Feb;148(3):263-71.

PMID:
10755739
35.
36.

Further characterization of the discriminative stimulus effects of spiradoline.

Holtzman SG.

Pharmacol Biochem Behav. 2000 Jul;66(3):517-22.

PMID:
10899364
37.
38.

Modulation of the discriminative stimulus effects of d-amphetamine by mu and kappa opioids in squirrel monkeys.

Powell KR, Holtzman SG.

Pharmacol Biochem Behav. 2000 Jan 1;65(1):43-51.

PMID:
10638635
39.

Sensitization to daily morphine injections in rats with unilateral lesions of the substantia nigra.

Volpicelli LA, Easterling KW, Kimmel HL, Holtzman SG.

Pharmacol Biochem Behav. 1999 Nov;64(3):487-93.

PMID:
10548260
40.
41.
42.

Synthesis and pharmacology of site-specific cocaine abuse treatment agents: 2-(aminomethyl)-3-phenylbicyclo[2.2.2]- and -[2.2.1]alkane dopamine uptake inhibitors.

Deutsch HM, Collard DM, Zhang L, Burnham KS, Deshpande AK, Holtzman SG, Schweri MM.

J Med Chem. 1999 Mar 11;42(5):882-95.

PMID:
10072685
43.

Discriminative stimulus effects of naltrexone after a single dose of morphine in the rat.

Easterling KW, Holtzman SG.

J Pharmacol Exp Ther. 1999 Mar;288(3):1269-77.

PMID:
10027868
44.

Modulation of cocaine-induced antinociception by opioid-receptor agonists.

Waddell AB, Holtzman SG.

Pharmacol Biochem Behav. 1999 Feb;62(2):247-53.

PMID:
9972691
46.

Modulation of cocaine-induced motor activity in the rat by opioid receptor agonists.

Waddell AB, Holtzman SG.

Behav Pharmacol. 1998 Sep;9(5-6):397-407.

PMID:
9832925
47.
48.

Naloxone does not alter amphetamine-induced rotational behavior or striatal dopamine levels of nigrally-lesioned rats.

Kimmel HL, Schad CA, Justice JB Jr, Holtzman SG.

Brain Res. 1998 Apr 6;789(1):171-4.

PMID:
9602114
49.

Opioid receptor agonists and antagonists alter GBR12909-induced turning in the rat.

Kimmel HL, Holtzman SG.

Eur J Pharmacol. 1998 Feb 19;343(2-3):119-27.

PMID:
9570458
50.

Lack of NMDA receptor involvement in caffeine-induced locomotor stimulation and tolerance in rats.

Powell KR, Holtzman SG.

Pharmacol Biochem Behav. 1998 Feb;59(2):433-8.

PMID:
9476992

Supplemental Content

Loading ...
Support Center